It is a pharma private limited company based in Lucknow, Uttar Pradesh, India, established in 2009.
2009 | Lucknow, Uttar Pradesh, India | ActiveZecon Pharmaceuticals Private Limited, a active private limited company, was established on 04 February 2009 in Lucknow, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U93000UP2009PTC036720. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.30 M.
It upholds a compliant status. Its leadership includes Devraj Kishor (Director), Amit Rai (Director), Rajeev Kumar Dhondiyal (Director). Past directors included Ajit Jain. It holds ₹1.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 5/47, Vikas Nagar, Sector-5, Lucknow, Uttar Pradesh, 226022.
U93000UP2009PTC036720
036720
04 February 2009
₹2.50 M
₹1.30 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Zecon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devraj Kishor | Director | 04 Feb 2009 | Current |
| Amit Rai | Director | 04 Feb 2009 | Current |
| Rajeev Kumar Dhondiyal | Director | 04 Feb 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Dec 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zecon Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.33% increase. The company also saw a slight decrease in profitability, with a 2.91% decrease in profit. The company's net worth Soared by an impressive increase of 24.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Zecon Pharmaceuticals had a promoter holding of 62.62% and a public holding of 37.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jun 2014 | Union Bank Of India | ₹0.50 M | Open |
| 02 Jun 2014 | Union Bank Of India | ₹0.50 M | Open |
| 02 Jun 2014 | Union Bank Of India | ₹0.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Zecon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Zecon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zecon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Zecon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Zecon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.
The activity A charge with Union Bank Of India amounted to Rs. 0.50 M with Charge ID 10507564 was registered on 02 Jun 2014. was completed.
The activity A charge with Union Bank Of India amounted to Rs. 0.50 M with Charge ID 10507568 was registered on 02 Jun 2014. was completed.
Progress on A charge with Union Bank Of India amounted to Rs. 0.50 M with Charge ID 10507217 was registered on 02 Jun 2014. was documented.
Devraj Kishor was appointed as a Director was appointed as a Director on 04 Feb 2009 & has been associated with this company since 16 years 10 months . was recorded as a recent event.
The CIN of Zecon Pharmaceuticals Private Limited is U93000UP2009PTC036720.
Zecon Pharmaceuticals Private Limited is headquartered at 5/47, Vikas Nagar, Sector-5, Lucknow, Uttar Pradesh, 226022.
Zecon Pharmaceuticals Private Limited was incorporated on 04 February 2009.
The current directors of Zecon Pharmaceuticals Private Limited are
The primary industry of Zecon Pharmaceuticals Private Limited is Manufacturing.
Zecon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Zecon Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹1.30 M.
The compliance status of Zecon Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX